MorphoSys is a commercial-stage biopharmaceutical company dedicated to the discovery, development, and delivery of innovative cancer medicines.
MorphoSys has a broad mid- to late-stage pipeline with a focus on hematology and oncology.
MorphoSys applies state-of-the-art research capabilities and expertise in novel discovery platforms to develop new compounds.
You are now leaving the MorphoSys.com website. This link will take you to a different website. You are solely responsible for your interactions with that website.
Do you wish to proceed ?